Neuroone Medical Technologies (NMTC) Revenue (2011 - 2026)

Neuroone Medical Technologies has disclosed Revenue across 12 years of filings, most recently posting $1.9 million for Q1 2026.

• Quarterly Revenue rose 34.29% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (up 59.61% YoY) and the FY2025 annual result came in at $9.1 million, up 163.47% from the prior year.
• Revenue retreated to $1.9 million in Q1 2026, from $2.9 million in the prior quarter.
• Across five years, Revenue topped out at $3.3 million in Q4 2024 and bottomed at $32049.0 in Q2 2022.
• The 5-year median for Revenue is $825776.0 (2024), against an average of $1.1 million.
• Year-over-year, Revenue jumped 1865.45% in 2023 and sank 63.29% in 2024.
• Neuroone Medical Technologies' Revenue stood at $114579.0 in 2022, then jumped by 753.25% to $977649.0 in 2023, then jumped by 234.9% to $3.3 million in 2024, then retreated by 11.65% to $2.9 million in 2025, then slumped by 35.63% to $1.9 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.9 million, $2.9 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.